• By ICR Secretariat
  • Posted Wednesday, November 20, 2019

Solid gene therapy trial halted again by FDA

https://www.biopharmadive.com/news/fda-clinical-hold-solid-duchenne-gene-therapy/567144/

The Food and Drug Administration ordered a clinical hold on a trial of Solid Biosciences' gene therapy for Duchenne muscular dystrophy after a patient experienced an immune response accompanied with blood, kidney, heart and lung complications.